Long-term efficacy of boosted and unboosted atazanavir-containing regimens: results from the SCOLTA Project (original) (raw)
Raltegravir, etravirine and darunavir-ritonavir: a safe and successful rescue regimen in highly treatment-experienced HIV1-infected patients
Mario Rivas
Journal of The International Aids Society, 2008
View PDFchevron_right
Risk factors for end-stage liver disease among HIV and hepatitis C virus co-infected patients in the Spanish VACH Cohort
I Suarez-Lozano, A. Munoz-sanz
Journal of the International AIDS Society, 2008
View PDFchevron_right
Eligibility and Feasibility of the Treatment of Chronic Hepatitis C in a Cohort of Italian HIV-Positive Patients at a Single HIV Reference Center
Paola Meraviglia
AIDS Patient Care and STDs, 2011
View PDFchevron_right
Switching to nevirapine-based HAART in virologically-suppressed patients: influence of a longer twice-daily induction period on once-a-day dosing
Anna Orani
Journal of the International AIDS Society, 2008
View PDFchevron_right
Darunavir in patients who failed on fos-amprenavir: efficacy at week 48
Kabamba Kabeya
Journal of the International AIDS Society, 2008
View PDFchevron_right
Is prognosis after first AIDS-defining pathology incidence becoming better in recent years of HAART era
JJ SAnz
Journal of The International Aids Society, 2008
View PDFchevron_right
Efficacy, safety and tolerability of enfuvirtide in a population of Portuguese HIV1 chronically infected patients
Roberto Camacho
Journal of The International Aids Society, 2008
View PDFchevron_right
Exposition and sequencing to antiretrovirals in HIV1 patients with triple-class antiretroviral failure, and harbouring protease resistance mutations
Arnulfo Castro
Journal of The International Aids Society, 2008
View PDFchevron_right
Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study
Sanjay Bhagani
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2021
View PDFchevron_right
Hospital admissions and associated diagnosis of HIV patients in the HAART era
Saulo Cardoso
Journal of The International Aids Society, 2008
View PDFchevron_right
Low Rates of Sustained Virologic Response with Peginterferon Plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV Infected Patients in Rio de Janeiro, Brazil
Silvia Beatriz Cob May
Plos One, 2013
View PDFchevron_right
Body physical changes in HIV patients under antiretroviral treatment in Spain
A. Burgos
Journal of the International AIDS Society, 2008
View PDFchevron_right
Use of lopinavir/ritonavir in first-line therapy or second-line therapy: 48-week results from the German prospective STAR cohort
Axel Baumgarten
Journal of the International AIDS Society, 2008
View PDFchevron_right
Long-term safety and efficacy of nevirapine (NVP)-based antiretroviral therapies
Montse Garcia
Journal of The International Aids Society, 2008
View PDFchevron_right
A 4-year follow-up of a cohort of HIV-positive cirrhotic patients
Paula Tuma
Journal of the …, 2008
View PDFchevron_right
O414 48-week data from Study AVX-201 – a randomised phase IIb study of apricitabine in treatment-experienced patients with M184V and NRTI resistance
Marcelo H Losso
2008
View PDFchevron_right
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations
Jorge L Cisneros B
Journal of Viral Hepatitis, 2004
View PDFchevron_right
Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C)
Kenneth Sherman
JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
View PDFchevron_right
Effects on insulin sensitivity and hepatic safety of Atazanavir in HCV/HIV coinfected patients versus HIV monoinfected: A prostective 48-week study
Soledad Lopez
Retrovirology, 2010
View PDFchevron_right
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop
Anna Orani
AIDS reviews
View PDFchevron_right